Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01269190 · ClinicalTrials.gov registry record · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
A NA study of Oral Cavity Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 275
- Enrollment target
- 1
- Study location
NCT01269190: Recruiting NA study of Oral Cavity Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT01269190 is a NA study of Oral Cavity Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 275 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01269190, a NA study of Oral Cavity Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies wide-field and high resolution in vivo imaging in visualizing lesions in patients with abnormal or uncontrolled oral cell growth (neoplasia) undergoing surgery. Diagnostic procedures, such as wide-field and high resolution in vivo imaging, are devices that let researchers look at a wide area of the lining of the mouth by shining different colors inside the mouth and taking pictures and this may help doctors to decide if a mouth lesion has a high risk of being pre-cancerous or cancerous.
Primary Outcome
Images obtained will be compared against the histology slides of tissue taken from the same region.
Conditions Studied
Interventions
- PROCEDURE High-Resolution Microendoscopy
- PROCEDURE Multispectral Imaging
- DRUG Proflavine
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2010-12-30 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT01269190 shows while recruiting
NCT01269190 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Oral Cavity Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which High-Resolution Microendoscopy is the first listed.
NCT01269190 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01269190 about?
NCT01269190 is a clinical study titled "Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery". This clinical trial studies wide-field and high resolution in vivo imaging in visualizing lesions in patients with abnormal or uncontrolled oral cell growth (neoplasia) undergoing surgery. Diagnostic procedures, such as wide-field and high resolution in vivo imaging, are devices that let researchers...
What is the current status of trial NCT01269190?
This trial is currently recruiting. It is a NA study. The enrollment target is 275 participants. The study started on 2010-12-30. Estimated completion is 2028-12-31.
What conditions does trial NCT01269190 study?
This clinical trial studies the following conditions: Oral Cavity Neoplasm.
What interventions are being tested in trial NCT01269190?
The interventions under investigation include: High-Resolution Microendoscopy (PROCEDURE), Multispectral Imaging (PROCEDURE), Proflavine (DRUG).
Who is sponsoring clinical trial NCT01269190?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01269190 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01269190's enrollment target sits among peer trials
275 383rd of 2000 higher than 1,616 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
- NCT04960579 · 275 participants · Phase 1
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI